"Ophthalmology and Optometry group specializing in glasses, contact lenses, cataract surgery, LASIK, premium lenses, dry eyes, cornea, glaucoma, retina, and oculoplastic surgery. Our goal is to provide the best personalized care possible focused on your medical needs."

During the past decade, East West Eye Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East West Eye Institute" #1 sponsor was "Aerie Pharmaceuticals" with 1 trials, followed by "Aldeyra Therapeutics, Inc." with 1 trials sponsored, "Allergan" with 1 trials sponsored, "Faes Farma, S.A." with 1 trials sponsored and "HanAll BioPharma Co., Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East West Eye Institute" #1 collaborator was "Daewoong Pharmaceutical Co. LTD." with 1 trials as a collaborator and "ORA, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "East West Eye Institute" are "Allergic Conjunctivitis" (2 trials), "Glaucoma, Open-Angle" (2 trials), "Ocular Hypertension" (2 trials), "Bacterial Conjunctivitis" (1 trials) and "Dry Eye" (1 trials). Many other conditions were trialed in "East West Eye Institute" in a lesser frequency.

Most popular intervention types in "East West Eye Institute" are "Drug" (7 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AR-13324 Ophthalmic Solution 0.02%" (1 trials), "AR-13324 Ophthalmic Solution 0.04%" (1 trials), "AR-13324 Ophthalmic Solution Placebo" (1 trials) and "Active Comparator: Timolol 0.5%" (1 trials). Other intervention names were less common.

The vast majority of trials in "East West Eye Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "East West Eye Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in East West Eye Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in East West Eye Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".